These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 25879528

  • 61. High expression of TAZ indicates a poor prognosis in retinoblastoma.
    Zhang Y, Xue C, Cui H, Huang Z.
    Diagn Pathol; 2015 Oct 13; 10():187. PubMed ID: 26464030
    [Abstract] [Full Text] [Related]

  • 62. [The UGT1A, Nrf2 and Keap1 protein expression and significance in colon tumor].
    Wang M, Qi YY, Chen S, Liu L, Chen J, Li YQ.
    Zhonghua Nei Ke Za Zhi; 2012 Jul 13; 51(7):531-5. PubMed ID: 22943825
    [Abstract] [Full Text] [Related]

  • 63. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
    Bachet JB, Maréchal R, Demetter P, Bonnetain F, Couvelard A, Svrcek M, Bardier-Dupas A, Hammel P, Sauvanet A, Louvet C, Paye F, Rougier P, Penna C, Vaillant JC, André T, Closset J, Salmon I, Emile JF, Van Laethem JL.
    Ann Oncol; 2012 Sep 13; 23(9):2327-2335. PubMed ID: 22377565
    [Abstract] [Full Text] [Related]

  • 64. Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer.
    Zhang L, Yang WP, Wu LY, Zhu X, Wei CY.
    Genet Mol Res; 2016 May 12; 15(2):. PubMed ID: 27323010
    [Abstract] [Full Text] [Related]

  • 65. Prognostic Factors for Pancreatic Cancer Patients Treated with Immune-cell Therapy.
    Makita K, Kamigaki T, Okada S, Matsuda E, Ibe H, Oguma E, Naitoh K, Takimoto R, Goto S.
    Anticancer Res; 2018 Jul 12; 38(7):4353-4360. PubMed ID: 29970573
    [Abstract] [Full Text] [Related]

  • 66. Correlation between spiral CT preoperative staging of pancreatic cancer and PTEN and COX-2 expression.
    Chun-Ye Q, Xun S, Ming G.
    Hepatogastroenterology; 2012 Sep 12; 59(118):2000-2. PubMed ID: 22389271
    [Abstract] [Full Text] [Related]

  • 67. HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome.
    Bengtsson E, Nerjovaj P, Wangefjord S, Nodin B, Eberhard J, Uhlén M, Borgquist S, Jirström K.
    Diagn Pathol; 2014 Apr 07; 9():78. PubMed ID: 24708688
    [Abstract] [Full Text] [Related]

  • 68. The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy.
    Roininen N, Haapasaari KM, Karihtala P.
    Oxid Med Cell Longev; 2017 Apr 07; 2017():2908039. PubMed ID: 29348788
    [Abstract] [Full Text] [Related]

  • 69. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma.
    Karihtala P, Soini Y, Vaskivuo L, Bloigu R, Puistola U.
    Int J Gynecol Cancer; 2009 Aug 07; 19(6):1047-51. PubMed ID: 19820366
    [Abstract] [Full Text] [Related]

  • 70. ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer.
    Purohit V, Wang L, Yang H, Li J, Ney GM, Gumkowski ER, Vaidya AJ, Wang A, Bhardwaj A, Zhao E, Dolgalev I, Zamperone A, Abel EV, Magliano MPD, Crawford HC, Diolaiti D, Papagiannakopoulos TY, Lyssiotis CA, Simeone DM.
    Genes Dev; 2021 Feb 01; 35(3-4):218-233. PubMed ID: 33446568
    [Abstract] [Full Text] [Related]

  • 71. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
    Qian Y, Sang Y, Wang FX, Hong B, Wang Q, Zhou X, Weng T, Wu Z, Zheng M, Zhang H, Yao H.
    Oncotarget; 2016 Nov 01; 7(44):72242-72249. PubMed ID: 27750217
    [Abstract] [Full Text] [Related]

  • 72. High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker.
    Xiao MB, Jiang F, Ni WK, Chen BY, Lu CH, Li XY, Ni RZ.
    Med Oncol; 2012 Sep 01; 29(3):1886-91. PubMed ID: 21912994
    [Abstract] [Full Text] [Related]

  • 73. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
    Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ, Ashley SW, Maitra A, Redston M, Whang EE.
    Ann Surg; 2005 Mar 01; 241(3):491-6. PubMed ID: 15729073
    [Abstract] [Full Text] [Related]

  • 74. High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer.
    Lee YS, Kang J, Jung ES, Lee A.
    J Breast Cancer; 2023 Oct 01; 26(5):461-478. PubMed ID: 37926068
    [Abstract] [Full Text] [Related]

  • 75. Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.
    Barbano R, Muscarella LA, Pasculli B, Valori VM, Fontana A, Coco M, la Torre A, Balsamo T, Poeta ML, Marangi GF, Maiello E, Castelvetere M, Pellegrini F, Murgo R, Fazio VM, Parrella P.
    Epigenetics; 2013 Jan 01; 8(1):105-12. PubMed ID: 23249627
    [Abstract] [Full Text] [Related]

  • 76. Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients.
    Jiang N, Xue R, Bu F, Tong X, Qiang J, Liu R.
    Int J Clin Exp Pathol; 2014 Jan 01; 7(7):4120-7. PubMed ID: 25120791
    [Abstract] [Full Text] [Related]

  • 77. Factors associated with the survival of prostate cancer patients with rectal involvement.
    Wang H, Yao Y, Li B.
    Diagn Pathol; 2014 Feb 20; 9():35. PubMed ID: 24555830
    [Abstract] [Full Text] [Related]

  • 78. Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.
    Zhou L, Yao LT, Liang ZY, Zhou WX, You L, Shao QQ, Huang S, Guo JC, Zhao YP.
    Int J Clin Exp Pathol; 2015 Feb 20; 8(11):14640-8. PubMed ID: 26823787
    [Abstract] [Full Text] [Related]

  • 79. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer.
    Huang J, Yao WY, Zhu Q, Tu SP, Yuan F, Wang HF, Zhang YP, Yuan YZ.
    Cancer Sci; 2010 Feb 20; 101(2):559-67. PubMed ID: 19922503
    [Abstract] [Full Text] [Related]

  • 80. Oxidative Stress-regulating Enzymes and Endometrial Cancer Survival in Relation to Metformin Intake in Diabetic Patients.
    Kuusiniemi E, Karihtala P, Puistola U, Ahtikoski A, Urpilainen E.
    Anticancer Res; 2023 Dec 20; 43(12):5545-5554. PubMed ID: 38030210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.